Green Pine(300132)
Search documents
业绩利好来了!000037,净利预增最高722%!
Zheng Quan Shi Bao Wang· 2026-01-22 15:44
Core Viewpoint - Multiple A-share listed companies are expected to significantly increase their performance in 2025, with notable growth in net profits compared to the previous year. Group 1: Company Performance Forecasts - Shenzhen Nanshan Electric (深南电A) anticipates a net profit attributable to shareholders of 150 million to 180 million yuan, representing a growth of 584.66% to 721.59% year-on-year, driven by asset disposals and improved operational management [1][2] - Lantian Co., Ltd. (闰土股份) projects a net profit of 600 million to 700 million yuan, an increase of 181.05% to 227.89% from the previous year, attributed to higher profits from active dyes and basic chemicals, as well as investment gains of approximately 330 million yuan [2][3] - Qingsong Co., Ltd. (青松股份) expects a net profit of 130 million to 165 million yuan, reflecting a growth of 137.73% to 201.74% year-on-year, supported by a recovery in the domestic cosmetics market and a significant impact from non-recurring gains of about 34 million yuan [3][4] - Tianhe Co., Ltd. (天禾股份) forecasts a net profit of 41 million to 60 million yuan, indicating an increase of 84.35% to 169.78% compared to the previous year, achieved through effective risk management and operational improvements despite a challenging agricultural market [4][5]
业绩利好来了!000037,净利预增最高722%!
证券时报· 2026-01-22 15:24
Core Viewpoint - Multiple A-share listed companies are expected to significantly increase their performance in 2025, with notable growth in net profits compared to the previous year [1][2]. Group 1: Company Performance Forecasts - ShenNan Electric A (000037) anticipates a net profit attributable to shareholders of 150 million to 180 million yuan, representing a growth of 584.66% to 721.59% compared to the previous year [1][3]. - LunTuo Co. (002440) expects a net profit of 600 million to 700 million yuan, an increase of 181.05% to 227.89% year-on-year, driven by improved profits from active dyes and basic chemicals [1][4]. - Qingsong Co. (300132) forecasts a net profit of 130 million to 165 million yuan, reflecting a growth of 137.73% to 201.74% year-on-year, supported by a recovery in the domestic cosmetics market [1][5]. - TianHe Co. (002999) projects a net profit of 41 million to 60 million yuan, indicating an increase of 84.35% to 169.78% compared to the previous year, despite challenges in the agricultural market [1][6]. Group 2: Key Financial Metrics - ShenNan Electric A's basic earnings per share are expected to be between 0.2489 yuan and 0.2986 yuan, compared to 0.0363 yuan in the previous year [3]. - LunTuo Co. anticipates basic earnings per share of 0.53 yuan to 0.62 yuan, up from 0.19 yuan year-on-year [4]. - Qingsong Co. expects basic earnings per share of 0.12 yuan to 0.17 yuan, compared to 0.06 yuan in the previous year [5]. - TianHe Co. projects basic earnings per share of 0.12 yuan to 0.17 yuan, an increase from 0.06 yuan year-on-year [6].
业绩预喜汇总 | 这家公司2025年净利最高同比预增超720%





Di Yi Cai Jing· 2026-01-22 13:58
Group 1 - ShenNan Electric A expects a net profit increase of 584.66%-721.59% year-on-year for 2025 [1] - Te Yi Pharmaceutical anticipates a net profit increase of 241.55%-339.13% year-on-year for 2025 [1] - RunTu Co. forecasts a net profit increase of 181.05%-227.89% year-on-year for 2025 [1] - QingSong Co. projects a net profit increase of 137.73%-201.74% year-on-year for 2025 [1] - RuiSheng Intelligent expects a net profit increase of 112.00%-139.99% year-on-year for 2025 [1] - JianKai Technology anticipates a net profit increase of 101.09%-121.20% year-on-year for 2025 [1] - XingQi Eye Medicine forecasts a net profit increase of 95.82%-121.56% year-on-year for 2025 [1] - RuiChuang MicroNano expects a net profit increase of approximately 93% year-on-year for 2025 [1] - TianHe Co. projects a net profit increase of 84.35%-169.78% year-on-year for 2025 [1] - ZhongYuan Co. anticipates a net profit increase of 80%-105% year-on-year for 2025 [1] - YiDao Information expects a net profit increase of 76.04%-128.85% year-on-year for 2025 [1] - ShengDa Bio forecasts a net profit increase of 69.93%-120.90% year-on-year for 2025 [1] - HuaRui Precision anticipates a net profit increase of 68.29%-86.99% year-on-year for 2025 [1] - FangZheng Technology expects a net profit increase of 67.06%-98.14% year-on-year for 2025 [1] - JinLing Hotel projects a net profit increase of 65.37%-90.93% year-on-year for 2025 [1] - QiangYi Co. anticipates a net profit increase of 57.87%-71.17% year-on-year for 2025 [1] - LangBo Technology expects a net profit increase of 57.58%-66.53% year-on-year for 2025 [1] - HuaFeng Measurement and Control forecasts a net profit increase of 46%-78% year-on-year for 2025 [1] - Zhaoyi Innovation anticipates a net profit increase of approximately 46% year-on-year for 2025 [1] - JieChang Drive expects a net profit increase of 40%-55% year-on-year for 2025 [1] - ShengYuan Environmental Protection projects a net profit increase of 31.79%-59.24% year-on-year for 2025 [1] - GuangHa Communication anticipates a net profit increase of 21.83%-31.31% year-on-year for 2025 [1] - MaiHe Co. expects a net profit increase of 19.58%-54.76% year-on-year for 2025 [1] Group 2 - YiLing Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, turning profitable year-on-year [1] - LiYade anticipates a net profit of 300 million to 380 million yuan for 2025, turning profitable year-on-year [1] - SiRuiPu expects a net profit of 165 million to 184 million yuan for 2025, turning profitable year-on-year [1] - DaMing City anticipates a net profit of 140 million to 165 million yuan for 2025, turning profitable year-on-year [1] - DaHeng Technology expects a net profit of 106 million yuan for 2025, turning profitable year-on-year [1] - GuangHua Technology projects a net profit of 85 million to 120 million yuan for 2025, turning profitable year-on-year [1] - BoTeng Co. expects a net profit of 80 million to 105 million yuan for 2025, turning profitable year-on-year [2] - ZhongBing HongJian anticipates a net profit of 34 million to 46 million yuan for 2025, turning profitable year-on-year [2]
青松股份2025年净利预增137.73%-201.74%
Bei Jing Shang Bao· 2026-01-22 13:28
Core Viewpoint - Qingsong Co., Ltd. expects a significant increase in net profit for 2025, driven by a recovery in the domestic cosmetics industry and increased customer demand [2] Group 1: Financial Performance - The company forecasts a net profit attributable to shareholders of 130 million to 165 million yuan for 2025, representing a year-on-year growth of 137.73% to 201.74% [2] - The projected operating revenue for the reporting period is approximately 2.218 billion yuan, reflecting a year-on-year increase of about 14.34% compared to 2024 [2] Group 2: Strategic Focus - The company has effectively implemented two strategic focuses: "focusing on customers" and "focusing on products," which have contributed to improved operational performance [2] - By actively selecting high-quality customers and focusing on high-quality orders, the company has enhanced its comprehensive competitiveness and profitability through meticulous management in various areas [2]
今日晚间重要公告抢先看——兆易创新预计2025年净利同比预增46%左右;白银有色称股票价格短期涨幅较大 存在交易风险
Jin Rong Jie· 2026-01-22 13:26
Major Announcements - Zhaoyi Innovation plans to use 500 million CNY of A-share fundraising to increase capital in its wholly-owned subsidiaries for the implementation of the DRAM project [1] - Haiguang Information's mid-2025 profit distribution plan includes a cash dividend of 0.09 CNY per share, totaling 209 million CNY [2] - *ST Biology has terminated the major asset restructuring plan to acquire 51% of Hunan Huize Biomedical Technology Co., Ltd. [3] - Fosun Pharma intends to spin off its subsidiary Fosun Antigen for independent listing on the Hong Kong Stock Exchange [4] - Jingchen Co. has set the inquiry transfer price at 82.85 CNY per share for the transfer of 13.1 million shares [5] Performance Forecasts - Zhaoyi Innovation expects a net profit of approximately 1.61 billion CNY for 2025, a year-on-year increase of about 46% [9] - Longying Precision anticipates a net profit decrease of 17.70% to 29.36% for 2025, estimating between 545 million CNY and 635 million CNY [9] - Ruichuang Micro-Nano forecasts a net profit of around 1.1 billion CNY for 2025, representing a 93% increase [10] - Nanjing Bank projects a net profit of 21.81 billion CNY for 2025, an 8.08% increase year-on-year [11] - Zhongyuan Co. expects a net profit increase of 80% to 105% for 2025, estimating between 139 million CNY and 158 million CNY [12] - Qiangyi Co. anticipates a net profit increase of 57.87% to 71.17% for 2025, estimating between 368 million CNY and 399 million CNY [13] - Liard expects a net profit of 300 million CNY to 380 million CNY for 2025, turning from a loss of 889 million CNY in the previous year [14] - Daheng Technology forecasts a net profit of approximately 106 million CNY for 2025, also turning from a loss [16] - Dongfeng Co. anticipates a net loss of 390 million CNY to 480 million CNY for 2025 [17] - Qing Song Co. expects a net profit increase of 137.73% to 201.74% for 2025, estimating between 130 million CNY and 165 million CNY [18] - SIRUI Co. forecasts a net profit of 165 million CNY to 184 million CNY for 2025, turning from a loss [19] - Shengmei Shanghai expects a revenue increase of 18.91% to 22.47% for 2025, estimating between 6.68 billion CNY and 6.88 billion CNY [20] - Yijun Co. anticipates a net loss of 11 million CNY to 14 million CNY for 2025 [21] - Saint Yuan Environmental Protection expects a net profit increase of 31.79% to 59.24% for 2025, estimating between 240 million CNY and 290 million CNY [22] - Lijun Co. forecasts a net profit decrease of 45.05% to 60.03% for 2025, estimating between 4.8 million CNY and 6.6 million CNY [23] - Xingqi Eye Medicine expects a net profit increase of 95.82% to 121.56% for 2025, estimating between 662 million CNY and 749 million CNY [25] - Beidou Star expects a net loss of 230 million CNY to 290 million CNY for 2025, reducing losses compared to the previous year [26] - Yiling Pharmaceutical anticipates a net profit of 1.2 billion CNY to 1.3 billion CNY for 2025, turning from a loss of 725 million CNY [27] - Zhijiang Bio forecasts a net loss of 32 million CNY to 47 million CNY for 2025, reducing losses compared to the previous year [28] - Yema Battery expects a net profit decrease of 58% to 70% for 2025, estimating between 45.83 million CNY and 64.17 million CNY [29] - Yunmei Energy anticipates a net loss of 410 million CNY to 470 million CNY for 2025 [30] - Yingfang Micro expects a net loss of 69 million CNY to 97 million CNY for 2025 [31] - Guanghua Technology forecasts a net profit of 85 million CNY to 120 million CNY for 2025, turning from a loss [33] Share Buybacks - Hengyi Petrochemical plans to repurchase shares worth 500 million CNY to 1 billion CNY [34] - Yunyi Electric plans to repurchase shares worth 100 million CNY to 150 million CNY [34] - Xidun Pharmaceutical plans to repurchase shares worth 25 million CNY to 50 million CNY [35]
青松股份:预计2025年净利同比增长137.73%-201.74%
Zhong Guo Zheng Quan Bao· 2026-01-22 12:22
Core Viewpoint - Qingsong Co., Ltd. (青松股份) expects significant growth in its 2025 performance, with projected revenue and net profit showing substantial year-on-year increases [4]. Financial Performance - The company anticipates a revenue of 2.218 billion yuan in 2025, representing a year-on-year growth of 14.34% [4]. - The expected net profit attributable to shareholders is between 130 million yuan and 165 million yuan, indicating a year-on-year increase of 137.73% to 201.74% [4]. - The forecasted net profit excluding non-recurring items is estimated to be between 96 million yuan and 131 million yuan, reflecting a growth of 73.29% to 136.47% year-on-year [4]. Valuation Metrics - As of January 22, the company's price-to-earnings ratio (TTM) is approximately between 29.05 and 36.88 times, with a price-to-book ratio (LF) of about 3.4 times and a price-to-sales ratio (TTM) of around 2.16 times [4]. - Historical price-to-earnings ratio trends indicate fluctuations over recent years, with the company’s TTM P/E ratio showing a range from 20 to 41 times [5][6]. Industry Context - The overall consumption in the domestic cosmetics industry is experiencing a steady recovery, which has positively impacted customer order demand for the company [13]. - The company’s performance improvement is also attributed to the completion of a land project disposal, which is expected to contribute approximately 34 million yuan to the net profit [13].
青松股份发预增,预计2025年度归母净利润1.3亿元至1.65亿元,增长37.73% 至201.74%
Zhi Tong Cai Jing· 2026-01-22 11:01
Core Viewpoint - Qingsong Co., Ltd. (300132.SZ) has disclosed its performance forecast for the year 2025, expecting a significant increase in net profit attributable to shareholders, indicating strong growth potential for the company [1] Financial Performance - The company anticipates a net profit of between 130 million yuan and 165 million yuan for 2025, representing a year-on-year growth of 137.73% to 201.74% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 96 million yuan and 131 million yuan, reflecting a year-on-year increase of 73.29% to 136.47% [1]
青松股份(300132.SZ)发预增,预计2025年度归母净利润1.3亿元至1.65亿元,增长37.73% 至201.74%
智通财经网· 2026-01-22 10:57
Core Viewpoint - Qingsong Co., Ltd. (300132.SZ) has disclosed its performance forecast for the year 2025, expecting a significant increase in net profit attributable to shareholders, indicating strong growth potential for the company [1] Financial Performance - The company anticipates a net profit of between 130 million to 165 million yuan, representing a year-on-year growth of 137.73% to 201.74% [1] - After excluding non-recurring gains and losses, the net profit is expected to be between 96 million to 131 million yuan, reflecting a year-on-year increase of 73.29% to 136.47% [1]
青松股份(300132.SZ):预计2025年净利润同比增长137.73%~201.74%
Ge Long Hui A P P· 2026-01-22 10:33
Group 1 - The core viewpoint of the article is that Qingsong Co., Ltd. (300132.SZ) expects a significant increase in net profit for 2025, projecting a range of 130 million to 165 million yuan, which represents a year-on-year growth of 137.73% to 201.74% [1] - The net profit after deducting non-recurring gains and losses is estimated to be between 96 million and 131 million yuan, indicating a year-on-year growth of 73.29% to 136.47% [1] - The overall consumption in the domestic cosmetics industry is showing a steady recovery, leading to an increase in customer order demand, which in turn drives the company's revenue growth [1] Group 2 - During the reporting period, the company achieved an operating revenue of approximately 2.218 billion yuan, reflecting a year-on-year increase of about 14.34% compared to 2024 [1]
青松股份:2025年净利同比预增137.73%—201.74%
Zheng Quan Shi Bao Wang· 2026-01-22 10:29
人民财讯1月22日电,青松股份(300132)1月22日发布业绩预告,预计2025年归母净利1.3亿元—1.65亿 元,同比增长137.73%—201.74%。报告期内,国内化妆品行业消费稳步复苏,公司客户订单需求增 长,带动营业收入同比增长14.34%。 ...